X

Articles

19Jul

Sample submission during the national blood shortage

0 Comments | | Return |

Through communications with our clients, CTS is aware of the current national blood shortage. We realize this situation makes it even more critical that we report your results on time. While most test result reporting delays are CTS’ responsibility, there are ways you can help reduce delays.

We have noted that some test result delays are associated with an inadequate donor sample set. The two primary causes are when only two tubes instead of three are submitted for routine donations or when three tubes instead of four are submitted for donations requiring Babesia testing. Another scenario that causes delays is when three tubes are submitted but one is unacceptable for testing, which could be due to low fill volume, a serum tube that isn’t clotted, or an EDTA tube with micro-clots. These scenarios require the donor testing laboratories to share a tube between testing platforms, which adds significant time to complete testing. All these scenarios cause test result reporting delays of up to 12 hours.

We suggest a reminder to staff that, especially during this critical shortage of blood products nationally, it is very important to completely fill the required number of sample tubes and to completely mix the filled tubes to ensure sample acceptability is attained.

We are developing improved client reports that will indicate the number of inadequate donor sets submitted by your facility, so that you can assess the frequency of these problems. The new report will be available for July testing data per request.
 

Impact to the Clients: 

Client Action Required:

  • We suggest a reminder to staff that it is very important to completely fill the appropriate number of donor tubes.
  • We suggest a reminder to staff that it is very important to completely mix the filled tubes to ensure an acceptable sample for testing.

Contact your CSM with any questions!

Related

CTS to Implement Licensed Babesia testing

In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols  ...

Read More >

CTS implements Ultrio Plus on the Panther

In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...

Read More >

Reminder-Check flights and cargo hours for the Labor Day Holiday

As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...

Read More >

Reminder-Bio-Rad Geenius HIV 1/2 Implemented

CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...

Read More >

FDA Updates Emergency Use Authorization for COVID-19 Convalescent Plasma

On December 28, 2021, the FDA updated the emergency use authorization  (EUA) for COVID-19 conva...

Read More >

CTS Phoenix Implements New Laboratory Information System

On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...

Read More >